124 related articles for article (PubMed ID: 15691875)
41. AR suppresses transcription of the alpha glycoprotein hormone subunit gene through protein-protein interactions with cJun and activation transcription factor 2.
Jorgensen JS; Nilson JH
Mol Endocrinol; 2001 Sep; 15(9):1496-504. PubMed ID: 11518798
[TBL] [Abstract][Full Text] [Related]
42. The roles of ATF2 (activating transcription factor 2) in tumorigenesis.
Gozdecka M; Breitwieser W
Biochem Soc Trans; 2012 Feb; 40(1):230-4. PubMed ID: 22260696
[TBL] [Abstract][Full Text] [Related]
43. Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress.
Hayakawa J; Mittal S; Wang Y; Korkmaz KS; Adamson E; English C; Ohmichi M; McClelland M; Mercola D
Mol Cell; 2004 Nov; 16(4):521-35. PubMed ID: 15546613
[TBL] [Abstract][Full Text] [Related]
44. Expression of the cyclic AMP-dependent transcription factors, CREB, CREM and ATF2, in the human myometrium during pregnancy and labour.
Bailey J; Sparey C; Phillips RJ; Gilmore K; Robson SC; Dunlop W; Europe-Finner GN
Mol Hum Reprod; 2000 Jul; 6(7):648-60. PubMed ID: 10871653
[TBL] [Abstract][Full Text] [Related]
45. Induction of CHOP expression by amino acid limitation requires both ATF4 expression and ATF2 phosphorylation.
Averous J; Bruhat A; Jousse C; Carraro V; Thiel G; Fafournoux P
J Biol Chem; 2004 Feb; 279(7):5288-97. PubMed ID: 14630918
[TBL] [Abstract][Full Text] [Related]
46. Partial oncogenic transformation of chicken embryo fibroblasts by Jun dimerization protein 2, a negative regulator of TRE- and CRE-dependent transcription.
Blazek E; Wasmer S; Kruse U; Aronheim A; Aoki M; Vogt PK
Oncogene; 2003 Apr; 22(14):2151-9. PubMed ID: 12687017
[TBL] [Abstract][Full Text] [Related]
47. c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors.
Fuchs SY; Xie B; Adler V; Fried VA; Davis RJ; Ronai Z
J Biol Chem; 1997 Dec; 272(51):32163-8. PubMed ID: 9405416
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of melanoma growth and metastasis by ATF2-derived peptides.
Bhoumik A; Gangi L; Ronai Z
Cancer Res; 2004 Nov; 64(22):8222-30. PubMed ID: 15548688
[TBL] [Abstract][Full Text] [Related]
49. TIP49b, a regulator of activating transcription factor 2 response to stress and DNA damage.
Cho SG; Bhoumik A; Broday L; Ivanov V; Rosenstein B; Ronai Z
Mol Cell Biol; 2001 Dec; 21(24):8398-413. PubMed ID: 11713276
[TBL] [Abstract][Full Text] [Related]
50. Amino-terminal-derived JNK fragment alters expression and activity of c-Jun, ATF2, and p53 and increases H2O2-induced cell death.
Buschmann T; Yin Z; Bhoumik A; Ronai Z
J Biol Chem; 2000 Jun; 275(22):16590-6. PubMed ID: 10748185
[TBL] [Abstract][Full Text] [Related]
51. Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival.
Berger AJ; Kluger HM; Li N; Kielhorn E; Halaban R; Ronai Z; Rimm DL
Cancer Res; 2003 Dec; 63(23):8103-7. PubMed ID: 14678960
[TBL] [Abstract][Full Text] [Related]
52. ATF2, a member of the CREB/ATF family of transcription factors, in chronic stress and consequent to antidepressant treatment: animal models and human post-mortem brains.
Laifenfeld D; Karry R; Grauer E; Klein E; Ben-Shachar D
Neuropsychopharmacology; 2004 Mar; 29(3):589-97. PubMed ID: 14647483
[TBL] [Abstract][Full Text] [Related]
53. Regulation of Gγ-globin gene by ATF2 and its associated proteins through the cAMP-response element.
Liu L; Karmakar S; Dhar R; Mahajan M; Choudhury A; Weissman S; Pace BS
PLoS One; 2013; 8(11):e78253. PubMed ID: 24223142
[TBL] [Abstract][Full Text] [Related]
54. Activation and interaction of ATF2 with the coactivator ASC-2 are responsive for granulocytic differentiation by retinoic acid.
Hong S; Choi HM; Park MJ; Kim YH; Choi YH; Kim HH; Choi YH; Cheong J
J Biol Chem; 2004 Apr; 279(17):16996-7003. PubMed ID: 14734562
[TBL] [Abstract][Full Text] [Related]
55. Stability of the ATF2 transcription factor is regulated by phosphorylation and dephosphorylation.
Fuchs SY; Tappin I; Ronai Z
J Biol Chem; 2000 Apr; 275(17):12560-4. PubMed ID: 10777545
[TBL] [Abstract][Full Text] [Related]
56. Association of activating transcription factor 2 (ATF2) with the ubiquitin-conjugating enzyme hUBC9. Implication of the ubiquitin/proteasome pathway in regulation of ATF2 in T cells.
Firestein R; Feuerstein N
J Biol Chem; 1998 Mar; 273(10):5892-902. PubMed ID: 9488727
[TBL] [Abstract][Full Text] [Related]
57. HvJNK, a Hydra member of the c-Jun NH2-terminal kinase gene family, is expressed during nematocyte differentiation.
Philipp I; Holstein TW; Hobmayer B
Gene Expr Patterns; 2005 Feb; 5(3):397-402. PubMed ID: 15661646
[TBL] [Abstract][Full Text] [Related]
58. Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer.
Choi CY; Choi BH; Park GT; Rho HM
J Biol Chem; 1997 Jul; 272(27):16934-9. PubMed ID: 9202004
[TBL] [Abstract][Full Text] [Related]
59. A cytoplasmic negative regulator isoform of ATF7 impairs ATF7 and ATF2 phosphorylation and transcriptional activity.
Diring J; Camuzeaux B; Donzeau M; Vigneron M; Rosa-Calatrava M; Kedinger C; Chatton B
PLoS One; 2011; 6(8):e23351. PubMed ID: 21858082
[TBL] [Abstract][Full Text] [Related]
60. Transcription factor ATF2 cooperates with v-Jun to promote growth factor-independent proliferation in vitro and tumor formation in vivo.
Huguier S; Baguet J; Perez S; van Dam H; Castellazzi M
Mol Cell Biol; 1998 Dec; 18(12):7020-9. PubMed ID: 9819389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
